Sofinnova Raises €750M for Life Sciences, Boosting Biotech Funding

Sofinnova Partners raises €650M for life sciences investments, with a focus on biotech startups and medical devices. Theyve already invested in Actithera and Elevara Medicines. This fundraising surge follows a strong third quarter for life sciences venture firms, with €6.1B raised, and is part of Sofinnovas €1.2B fundraising this year. Despite recent challenges in securing funding for young companies, Sofinnova remains committed to fostering innovation in the life sciences sector.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.